01 5Blake Cassels & Graydon LLP
01 52494234
01 5Paliperidone
01 1Extended Release Tablet
02 2Extended Release Tablets
03 2Extended release tablets
01 52023-07-28
Patent Expiration Date : 2023-07-28
Date Granted : 2009-10-27
Brand Name : INVEGA
Patent Number : 2494234
Filing Date : 2003-07-28
Strength per Unit : 3 mg
Dosage Form : Extended release tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-07-28
Date Granted : 2009-10-27
Patent Expiration Date : 2023-07-28
Date Granted : 2009-10-27
Brand Name : INVEGA
Patent Number : 2494234
Filing Date : 2003-07-28
Strength per Unit : 6 mg
Dosage Form : Extended release tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-07-28
Date Granted : 2009-10-27
Patent Expiration Date : 2023-07-28
Date Granted : 2009-10-27
Brand Name : INVEGA
Patent Number : 2494234
Filing Date : 2003-07-28
Strength per Unit : 9 mg
Dosage Form : Extended Release Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-07-28
Date Granted : 2009-10-27
Patent Expiration Date : 2023-07-28
Date Granted : 2009-10-27
Brand Name : INVEGA
Patent Number : 2494234
Filing Date : 2003-07-28
Strength per Unit : 12 mg
Dosage Form : Extended Release Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-07-28
Date Granted : 2009-10-27
Patent Expiration Date : 2023-07-28
Date Granted : 2009-10-27
Brand Name : INVEGA
Patent Number : 2494234
Filing Date : 2003-07-28
Strength per Unit : 1.5 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-07-28
Date Granted : 2009-10-27
